ConductScience.org, home

Trial · NCT03597464

Results by group86

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinAny treatment-emergent adverse event (TEAE)100Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleAny treatment-emergent adverse event (TEAE)80Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinTreatment-related TEAE28Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleTreatment-related TEAE21Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinSerious TEAE21Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleSerious TEAE23Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinTEAE leading to study drug discontinuation11Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleTEAE leading to study drug discontinuation17Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinTEAE leading to death0Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleTEAE leading to death3Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinTreatment-related TEAE leading to death0Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleTreatment-related TEAE leading to death0Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinDisease-related TEAE50Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleDisease-related TEAE34Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.VoclosporinDisease-related serious TEAE7Participants
Adverse Events (AE) Profile and Routine Biochemical and Hematological Assessments.Placebo Oral CapsuleDisease-related serious TEAE11Participants
Number (and Percent) of Subjects in Renal ResponseVoclosporinRenal Response - Month 1261Participants
Number (and Percent) of Subjects in Renal ResponsePlacebo Oral CapsuleRenal Response - Month 1234Participants
Number (and Percent) of Subjects in Renal ResponseVoclosporinRenal Response - Month 1874Participants
Number (and Percent) of Subjects in Renal ResponsePlacebo Oral CapsuleRenal Response - Month 1846Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03597464/results